LEADERS FREE: the balance of thrombosis and bleeding in patients at high-bleeding risk


LEADERS FREE is a trial in the news, focussing on high-bleeding risk patients, new types of stents and shortened DAPT, P. Urban walks us through one aspect of this much talked about trial, focussing on why they chose to turn their attention to patients at high-risk for bleeding; patients who are, most likely, at high-risk as well for thrombosis. Until now these individuals, which represent 20% of the cathlab population, have been excluded from clinical trials, leading to a critical lack of data concerning their treatment.

Learn why LEADERS FREE is changing that!